Ma A - Search Results

1

Interleukin-17 signaling triggers degradation of the constitutive NF-κB inhibitor ABIN-1.

Cruz JA, Childs EE, Amatya N, Garg AV, Beyaert R, Kane LP, Aneskievich BJ, Ma A, Gaffen SL. Cruz JA, et al. Among authors: ma a. Immunohorizons. 2017 Sep;1(7):133-141. doi: 10.4049/immunohorizons.1700035. Immunohorizons. 2017. PMID: 30761389 Free PMC article.

2

The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling.

Garg AV, Ahmed M, Vallejo AN, Ma A, Gaffen SL. Garg AV, et al. Among authors: ma a. Sci Signal. 2013 Jun 4;6(278):ra44. doi: 10.1126/scisignal.2003699. Sci Signal. 2013. PMID: 23737552 Free PMC article.

3

IL-17RC is critically required to maintain baseline A20 production to repress JNK isoform-dependent tumor-specific proliferation.

Yan C, Lei Y, Lin TJ, Hoskin DW, Ma A, Wang J. Yan C, et al. Among authors: ma a. Oncotarget. 2017 Jun 27;8(26):43153-43168. doi: 10.18632/oncotarget.17820. Oncotarget. 2017. PMID: 28562353 Free PMC article.

4

Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes.

Shembade N, Ma A, Harhaj EW. Shembade N, et al. Among authors: ma a. Science. 2010 Feb 26;327(5969):1135-9. doi: 10.1126/science.1182364. Science. 2010. PMID: 20185725 Free PMC article.

5

A20 and the noncanonical NF-κB pathway are key regulators of neutrophil recruitment during fetal ontogeny.

Rohwedder I, Wackerbarth LM, Heinig K, Ballweg A, Altstätter J, Ripphahn M, Nussbaum C, Salvermoser M, Bierschenk S, Straub T, Gunzer M, Schmidt-Supprian M, Kolben T, Schulz C, Ma A, Walzog B, Heinig M, Sperandio M. Rohwedder I, et al. Among authors: ma a. JCI Insight. 2023 Feb 22;8(4):e155968. doi: 10.1172/jci.insight.155968. JCI Insight. 2023. PMID: 36633909 Free PMC article.

6

A20 in hepatic stellate cells suppresses chronic hepatitis by inhibiting DCLK1-JNK pathway-dependent chemokines.

Watakabe K, Miyoshi M, Kakinuma S, Sato A, Tsuchiya J, Shimizu T, Mochida T, Inada K, Kaneko S, Kawai-Kitahata F, Murakawa M, Nitta S, Nakagawa M, Oshima S, Watanabe M, Ma A, Asahina Y, Okamoto R. Watakabe K, et al. Among authors: ma a. FASEB J. 2024 Jul 15;38(13):e23757. doi: 10.1096/fj.202400109R. FASEB J. 2024. PMID: 38965999

7

Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases.

Musone SL, Taylor KE, Nititham J, Chu C, Poon A, Liao W, Lam ET, Ma A, Kwok PY, Criswell LA. Musone SL, et al. Among authors: ma a. Genes Immun. 2011 Apr;12(3):176-82. doi: 10.1038/gene.2010.64. Epub 2011 Feb 17. Genes Immun. 2011. PMID: 21326317 Free PMC article.

8

Encoding NF-kappaB temporal control in response to TNF: distinct roles for the negative regulators IkappaBalpha and A20.

Werner SL, Kearns JD, Zadorozhnaya V, Lynch C, O'Dea E, Boldin MP, Ma A, Baltimore D, Hoffmann A. Werner SL, et al. Among authors: ma a. Genes Dev. 2008 Aug 1;22(15):2093-101. doi: 10.1101/gad.1680708. Genes Dev. 2008. PMID: 18676814 Free PMC article.

9

A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response.

Ashida H, Kim M, Schmidt-Supprian M, Ma A, Ogawa M, Sasakawa C. Ashida H, et al. Among authors: ma a. Nat Cell Biol. 2010 Jan;12(1):66-73; sup pp 1-9. doi: 10.1038/ncb2006. Epub 2009 Dec 13. Nat Cell Biol. 2010. PMID: 20010814 Free PMC article.

10

Direct, noncatalytic mechanism of IKK inhibition by A20.

Skaug B, Chen J, Du F, He J, Ma A, Chen ZJ. Skaug B, et al. Among authors: ma a. Mol Cell. 2011 Nov 18;44(4):559-71. doi: 10.1016/j.molcel.2011.09.015. Mol Cell. 2011. PMID: 22099304 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,713 results

Search Page

Filters